The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Johnson & Johnson has a strong business, several growth opportunities, and a safe dividend. The company does face headwinds, but it should be able to overcome them. Some might describe Johnson ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart failure, ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Several Chicago aldermen responded to Mayor Brandon Johnson's defiant posture towards the Trump administration's immigration policies. The aldermen were asked if Johnson and city officials were ...

Speaker Mike Johnson (R-La.) on Wednesday described President Trump’s idea that the U.S. should take over the Gaza Strip as “bold” and “decisive,” even as it draws bipartisan criticism.

Feb 5 (Reuters) - Johnson Controls International (JCI.N), opens new tab named Joakim Weidemanis as chief executive officer and lifted its 2025 profit forecast on Wednesday, sending its shares up ...